Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-001486
Filing Date
2015-08-06
Accepted
2015-08-06 16:28:24
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kyth-20150630x10q.htm 10-Q 1512301
2 EX-10.1 kyth-20150630ex1015bd088.htm EX-10.1 148277
3 EX-31.1 kyth-20150630ex31139341b.htm EX-31.1 11080
4 EX-31.2 kyth-20150630ex312dbe8b6.htm EX-31.2 11078
5 EX-32.1 kyth-20150630ex32163dd0e.htm EX-32.1 8883
  Complete submission text file 0001558370-15-001486.txt   6043845

Data Files

Seq Description Document Type Size
6 EX-101.INS kyth-20150630.xml EX-101.INS 1200627
7 EX-101.SCH kyth-20150630.xsd EX-101.SCH 45821
8 EX-101.CAL kyth-20150630_cal.xml EX-101.CAL 47761
9 EX-101.DEF kyth-20150630_def.xml EX-101.DEF 169656
10 EX-101.LAB kyth-20150630_lab.xml EX-101.LAB 430553
11 EX-101.PRE kyth-20150630_pre.xml EX-101.PRE 308943
Mailing Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301
Business Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301 818-587-4500
KYTHERA BIOPHARMACEUTICALS INC (Filer) CIK: 0001436304 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35663 | Film No.: 151033541
SIC: 2834 Pharmaceutical Preparations